428 Oakmead Parkway
About Apostle Inc.
Apostle is a biotechnology company developing a novel bioinformatics-enabled nanotechnology aimed for early cancer detection. This new approach will enable the early assessment of the cancerous signals in human peripheral blood plasma, which is believed to have a significant impact on the global healthcare landscape in both developed countries and emerging markets.
March 28, 2017
Founder and CEO: Dr. David Dongliang Ge
VP, Chemistry: Bo Zhang, PhD.
VP, Bioinformatics: Xin Guo, PhD.
Chief Medical Advisor: Wenqi Zeng, MD. PhD. FACMG
5 articles with Apostle Inc.
Ilan Danieli, chief executive officer and co-founder of Precipio, a company with a liquid biopsy technology, took time to talk to BioSpace about the company and the economics of liquid biopsies.
1/29/2018Apostle, headquartered in Sunnyvale, Calif., hopes to file an IPO or establish other strong business collaborative routes in five years.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.